PT Jayamas Medica Industri Tbk (IDX: OMED)

OMED Statistics

Total Valuation

PT Jayamas Medica Industri Tbk has a market cap or net worth of IDR 4.82 trillion. The enterprise value is 3.79 trillion.

Market Cap	4.82T
Enterprise Value	3.79T

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	Jun 20, 2024

Share Statistics

PT Jayamas Medica Industri Tbk has 27.06 billion shares outstanding. The number of shares has decreased by -10.11% in one year.

Current Share Class	n/a
Shares Outstanding	27.06B
Shares Change (YoY)	-10.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.79%
Owned by Institutions (%)	0.39%
Float	4.04B

Valuation Ratios

The trailing PE ratio is 16.73.

PE Ratio	16.73
Forward PE	n/a
PS Ratio	2.62
PB Ratio	2.05
P/TBV Ratio	2.05
P/FCF Ratio	16.79
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.59, with an EV/FCF ratio of 13.21.

EV / Earnings	13.16
EV / Sales	2.06
EV / EBITDA	9.59
EV / EBIT	11.25
EV / FCF	13.21

Financial Position

The company has a current ratio of 7.22, with a Debt / Equity ratio of 0.08.

Current Ratio	7.22
Quick Ratio	4.96
Debt / Equity	0.08
Debt / EBITDA	0.46
Debt / FCF	0.63
Interest Coverage	17.00

Financial Efficiency

Return on equity (ROE) is 12.74% and return on invested capital (ROIC) is 8.54%.

Return on Equity (ROE)	12.74%
Return on Assets (ROA)	8.09%
Return on Capital (ROIC)	8.54%
Revenue Per Employee	1.53B
Profits Per Employee	239.32M
Employee Count	1,111
Asset Turnover	0.71
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.67%
50-Day Moving Average	176.18
200-Day Moving Average	189.31
Relative Strength Index (RSI)	43.20
Average Volume (20 Days)	4,030,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Jayamas Medica Industri Tbk had revenue of IDR 1.84 trillion and earned 287.90 billion in profits. Earnings per share was 10.64.

Revenue	1.84T
Gross Profit	599.80B
Operating Income	336.65B
Pretax Income	368.34B
Net Income	287.90B
EBITDA	378.53B
EBIT	336.65B
Earnings Per Share (EPS)	10.64

Balance Sheet

The company has 1.24 trillion in cash and 180.41 billion in debt, giving a net cash position of 1.06 trillion or 39.25 per share.

Cash & Cash Equivalents	1.24T
Total Debt	180.41B
Net Cash	1.06T
Net Cash Per Share	39.25
Equity (Book Value)	2.38T
Book Value Per Share	86.89
Working Capital	1.91T

Cash Flow

In the last 12 months, operating cash flow was 393.87 billion and capital expenditures -107.06 billion, giving a free cash flow of 286.80 billion.

Operating Cash Flow	393.87B
Capital Expenditures	-107.06B
Free Cash Flow	286.80B
FCF Per Share	10.60

Margins

Gross margin is 32.69%, with operating and profit margins of 18.35% and 15.69%.

Gross Margin	32.69%
Operating Margin	18.35%
Pretax Margin	20.07%
Profit Margin	15.69%
EBITDA Margin	20.63%
EBIT Margin	18.35%
FCF Margin	15.63%

Dividends & Yields

This stock pays an annual dividend of 5.76, which amounts to a dividend yield of 3.29%.

Dividend Per Share	5.76
Dividend Yield	3.29%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	27.07%
Buyback Yield	10.11%
Shareholder Yield	13.40%
Earnings Yield	5.98%
FCF Yield	5.95%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PT Jayamas Medica Industri Tbk has an Altman Z-Score of 11.73.

Altman Z-Score	11.73
Piotroski F-Score	n/a